翔安生醫

AcuSense BioMedical Technology Co., Ltd.

Founded in 2017, we are dedicated to developing innovative healthcare solutions using cutting-edge artificial intelligence (AI) and Internet of Things (IoT) technologies. Our core objective is to improve clinical efficiency, patient safety, and overall quality of care.

Founded in 2017, AcuSense BioMedical Technology Co., Ltd. is dedicated to developing innovative medical solutions using cutting-edge artificial intelligence (AI) and Internet of Things (IoT) technologies. Our core objective is to improve clinical efficiency, patient safety, and overall quality of healthcare.

2025.11

Become a Microsoft Cloud Services reseller & AI Cloud Partner

2025.11

Certified by ISO 13485 Medical Device Quality Management System

2025.05

Selected to participate in the Startup to Europe Deep-roots Program, traveling to Poland to expand into the international market and enhance brand awareness.

2025.01

Attended the Consumer Electronics Show (CES 2025) in the United States.

2024.10

Launch of Smart Ward POC Project in Three Ministry-affiliated Hospitals

2024.10

Gitex exhibits in Dubai, Middle East

2023.06

Signed an agreement to cooperate with IKEM, the largest medical research center in the Czech Republic.

2023.03

Selected as a Czech accelerator Caelestinus Healthtech Incubator

2022.11

Attended MEDICA in Düsseldorf, Germany and a visit by medical device industry professionals in Prague, Czech Republic.

2022.09

Selection through the National Science Council (NSTC) x MEDICA 2022 in Germany

2021.12

Top 10 in Qualcomm Taiwan Innovation Competition

2021.08

The clinical trial at Tainan Municipal An-Nan Hospital has been approved. [IRB No.: TMANHIIO· C024]

2021.07

Shortlisted for the 9th Cloud Leopard Incubation Competition, collaborating with Lingqun Computer

2021.05

Two papers were selected as Best Conference Papers at the 3rd IEEE ECBIOS 2021.

2021.01

Selected as a team of TAcc Propel Accelerator from the Small and Medium Enterprise Administration

2020.06

Published clinical research findings from the European Association for the Study of Nephrology (ERA-EDTA 2020)

2020.04

Launching an overseas strategic alliance with Hugui Xingye and Zhengmei Group

2020.04

Potential proposals for the MIT COVID-19 Hackathon challenge

2020.02

BE Accelerator Team Selected

2019.12

The 16th National Innovation Award

2019.11

Award Winner of the "AI Smart Application New Generation Talent Cultivation Program" by the Industrial Development Bureau, Ministry of Economic Affairs